Xilio Therapeutics, Inc.

XLO ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $71.1M

Liabilities Breakdown FY2024

Total Liabilities: $53.5M